Fertigo Medical Ltd. was founded in 2014. With funds from its founders and twice from Israeli Office of the Chief Scientist (aka the Innovation Authority), the company was able to achieve several milestones, including:
- Built IP (Intellectual Property) portfolio, including one patent in national phase (9 territories, cleared in the EU, Russia and Australia) with the aid of the IP firm Reinhold-Cohn Patent attorney office . Additional patents submitted for priority.
- Fully developed automatic software.
- Successfully completed preclinical trials.
- On-going clinical trials.
Dr. Tsafrir Kolatt
CEO & Co-founder (PhD in Physics), 20 years in bio-technology and medical devices (CEO, EVP, R&D). Deputy CEO of Medigus (TASE, NASDAQ: MDGS). Has led successful FDA/CE processes in several companies.
Dr. Yuval Or
Medical Director (MD), is a senior IVF expert at Kaplan Medical Center and has served as the Head of the Gynecology Education Program there for MDs at the Hebrew University of Jerusalem.
Mr. Oded Tamir
Executive Chairperson (MBA. B.Sc. in Economics), Senior C level executive with more than 25 years ineternational experience in medical devices in the Israeli as co-founder, CEO, COO & CFO and various Board membership positions. Led over $250M funding and more than $ 750M in sales and M&A transactions.
Fertigo's team is led by: